Otsuka 

$20.00
15
+$0.00+0%Wednesday 20:00

Statistics

Day High
20
Day Low
20
52W High
21.57
52W Low
19
Volume
250
Avg. Volume
3
Mkt Cap
7.6B
P/E Ratio
26.69
Dividend Yield
3.13%
Dividend
0.63

Upcoming

Dividends

3.13%Dividend Yield
Sep 2026
$0.35
Mar 2026
$0.28
Sep 2025
$0.30
Mar 2025
$0.03
Mar 2025
$0.50
10Y Growth
7.18%
5Y Growth
11.7%
3Y Growth
16.96%
1Y Growth
-16.67%

Earnings

Feb 3Expected
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
0.18
0.24
0.3
0.35
Expected EPS
0.2698004953149
Actual EPS
N/A

Financials

4.87%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
8.75BRevenue
425.57MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OSUKF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Roche
RHHBY
Mkt Cap334.28B
Roche operates in similar pharmaceutical and diagnostics segments, competing directly in the development of innovative drugs and health solutions.
Pfizer
PFE
Mkt Cap167.52B
Pfizer competes in the pharmaceutical sector, offering a wide range of products that overlap with Otsuka's portfolio, including mental health medications.
Johnson & Johnson
JNJ
Mkt Cap664.95B
Johnson & Johnson's broad healthcare portfolio, including pharmaceuticals and medical devices, positions it as a competitor across several of Otsuka's business areas.
Novartis
NVS
Mkt Cap307B
Novartis competes in pharmaceuticals and healthcare, offering products in areas like neurology and psychiatry, directly competing with Otsuka's offerings.
Merck
MRK
Mkt Cap361.73B
Merck operates in the pharmaceutical industry, competing with Otsuka in areas such as healthcare solutions and drug development.
Abbvie
ABBV
Mkt Cap514.92B
AbbVie, with its strong presence in the pharmaceuticals sector, competes in areas of mutual interest like neuroscience and oncology.
Takeda Pharmaceutical
TAK
Mkt Cap67.16B
Takeda Pharmaceutical Company has a significant overlap with Otsuka in the pharmaceutical sector, especially in Japan, competing in similar therapeutic areas.
GSK
GSK
Mkt Cap100.88B
GlaxoSmithKline competes with Otsuka in the pharmaceutical and healthcare sectors, including areas like mental health.
Sanofi
SNY
Mkt Cap112.71B
Sanofi operates globally in the pharmaceutical sector, competing with Otsuka in various therapeutic areas, including mental health and neurology.
Astrazeneca
AZN
Mkt Cap289.14B
AstraZeneca is a global competitor in the pharmaceutical industry, with a product range that competes with Otsuka's, especially in the oncology and neurology segments.

About

Established in Tokyo, Japan, in 1961, Otsuka Corporation offers a comprehensive range of technology services within Japan. Its operations are primarily divided into two main segments: System Integration and Service & Support. The System Integration segment delivers end-to-end solutions, encompassing client consultation, system design and development, transportation and installation, and network construction. It also provides management systems and collaborative software like ERP packages and groupware, catering to specialized domains such as CAD and web technologies. Additionally, this segment facilitates the building and expansion of computer networks by offering computers, copiers, communication equipment, and software, including intranet and security products, as well as engaging in custom software development. The Service and Support segment focuses on ensuring operational continuity. This includes supplying consumables, performing hardware and software maintenance, and offering telephone support. It also provides outsourcing services, critical emergency computer rescue for both corporate and individual clients, and comprehensive network support from planning and design to the construction and ongoing management of corporate information systems. Furthermore, this segment outsources system engineers and delivers educational assistance.
Show More
CEO
Yuji Otsuka
Employees
10079
Country
Japan
ISIN
JP3188200004
WKN
000502503

Listings

0 Comments

Share your thoughts

FAQs

What is Otsuka stock price today?▼
The current price of OSUKF is $20.00 USD — it has increased by +0% in the past 24 hours. Watch Otsuka stock price performance more closely on the chart.
What is Otsuka stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Otsuka stocks are traded under the ticker OSUKF.
Is Otsuka stock price growing?▼
OSUKF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Otsuka has showed a -13.19% decrease.
What is Otsuka market cap?▼
Today Otsuka has the market capitalization of 7.6B
When is the next Otsuka earnings date?▼
Otsuka is going to release the next earnings report on February 3, 2027.
What were Otsuka earnings last quarter?▼
OSUKF earnings for the last quarter are 0.21 USD per share, whereas the estimation was 0.2 USD resulting in a +8.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Otsuka revenue for the last year?▼
Otsuka revenue for the last year amounts to 8.75B USD.
What is Otsuka net income for the last year?▼
OSUKF net income for the last year is 425.57M USD.
Does Otsuka pay dividends?▼
Yes, OSUKF dividends are paid semi-annual. The last dividend per share was 0.35 . As of today, Dividend Yield (FWD)% is 3.13%.
How many employees does Otsuka have?▼
As of November 14, 2026, the company has 10,079 employees.
In which sector is Otsuka located?▼
Otsuka operates in the Technology sector.
When did Otsuka complete a stock split?▼
The last stock split for Otsuka was on March 28, 2024 with a ratio of 2:1.
Where is Otsuka headquartered?▼
Otsuka is headquartered in Tokyo, Japan.